ABCG2 and colorectal carcinoma: It may also be regulated by lncRNA ZFAS1, whereas ABCG2 high expression presenting CRC subgroup may be resistant to the anti-EGFR therapy, demonstrating higher proteolytical activity and actin-filament-related activity, thus higher ability to invade surrounding tissue.